Bicara Therapeutics Inc.

01/27/2025 | Press release | Distributed by Public on 01/27/2025 07:00

Bicara Therapeutics Presents Phase 1/1b Dose Expansion Results with Ficerafusp Alfa in Advanced Squamous Cancer of the Anal Canal at the 2025 ASCO Gastrointestinal Cancers[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.